medigraphic.com
SPANISH

Revista Médica MD

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2017, Number 4

<< Back Next >>

Rev Med MD 2017; 8.9 (4)

Frequency of inborn errors of metabolism on pediatric patients in the Fray Antonio Alcalde Civil Hospital of Guadalajara

García-Morales E, Ferráez-Pech MA, López-Hernández RD, Gutiérrez-Padilla JA, Angulo-Castellanos E, Partido-Ramírez A, Valdez-Núñez AL, Sandoval-Tena M
Full text How to cite this article

Language: Spanish
References: 11
Page: 146-153
PDF size: 582.72 Kb.


Key words:

mass metabolic screening, innate error of metabolism.

ABSTRACT

Introduction. Inborn errors of metabolism (IEM) are a heterogeneous group of congenital diseases whose importance lies in the elevated morbimortality and the disability of those who have it. More than 600 IEMs have been described, and almost 25% of them affect since the neonatal period. It is important to know its frequency in each hospital unit, as to why the objective is to identify the frequency of inborn errors of metabolism and its relation to gender, gestational age, weight, and age at the time of the sample collection for the metabolic screening test on pediatric patients at the Fray Antonio Alcalde Civil Hospital of Guadalajara.
Material and Methods. Observational, cross-sectional, and analytical study performed during the period of September 2015 to August 2016. The patient files of 2,395 3 days old infants' who underwent the wide metabolic screening test were revised. A second confirmation was considered. The rates and frequencies were determined. The relation of variables was searched with Pearson's Chi-squared test through SPSS version 24 software.
Results. The samples of 2,313 infants were reported normal and 82 with suspicion of IEM. On the second sample, 56 were found with no pathologies, 6 were not localized, 4 deaths were registered, 15 were positive for IEM with a rate of 6/1000, and 1 case is still awaiting results. In order of frequency the diagnostics were: 7 Hemoglobinopathy S cases, 1 Bart Hemoglobinopathy case, 3 Glucose-6-phosphate dehydrogenase deficiency cases, 2 congenital suprarenal hyperplasia cases, 1 disorders of amino acids case, 1 congenital hyperthyroidism case. The statistical analysis showed no relation to IEM to gender nor days of age at the time of sample collection, while they were related to gestational age (55/0.006), and weight at the time of the sample collection 71.0/0.000.
Discussion. In this study the rate of 6/1000 was larger to other researches which report 1/1000, perhaps related to the method used and the third level hospital. The frequency of each of the IEMS was no different than those already reported. It is important to emphasize that it was observed that the younger gestational age and lower weight at the time of the sample collection a higher percentage of false positives, which were disproved with a confirmatory test. It proves to be of vital importance to continue with the metabolic screening in these type of institutions, in addition to evaluating if it is pertinent to normalize the gestational age and the weight at the time of the of sample collection in order to avoid false positives.


REFERENCES

  1. 1.Tamiz neonatal, detección, diagnóstico, tratamiento y seg uimiento de los Er rores I nna tos del Metabolismo. Lineamiento Técnico. Secretaría de Salud Centro Nacional de Equidad de Género y Salud Reproductiva. 2010.

  2. Gómez M. Clasificación de los niños recién nacidos. Revista Mexicana de Pediatría 2012;79(1):32-39.

  3. Giugliani R. Importancia de los registros nacionales e internacionales de errores innatos del metabolismo. Acta Pediátrica Mexicana 2012;33(6):329-330.

  4. Gómez M. Pautas para el diagnóstico temprano de los errores innatos del metabolismo. Revista Mexicana de Pediatría 2006;73(3):139-147.

  5. Alfadhel. Thirteen year retrospective review of the spectrum of inborn errors of metabolism presenting in a tertiary center in Saudi Arabia. Orphanet Journal of Rare Diseases 2016;11:126.

  6. Prevención, diagnóstico y tratamiento del Hipotiroidismo Congénito Neonatal en el Primer Nivel de Atención. Guía de práctica clínica. Catálogo Maestro: ISSSTE-135 08.

  7. Leyva D. Tamiz Neonatal Ampliado. Archivos Salud Sinaloa 2012;6(1):28-29.

  8. Erna B. Diagnóstico de errores innatos del metabolismo. Revista Chilena Pediátrica 2008;79(1): 92-95.

  9. Vela M. Frecuencia de enfermedades metabólicas congénitas susceptibles de ser identificadas por el tamiz neonatal. Acta Pediátrica Mexicana 2009;30(3):156-62.

  10. Deficiencia de glucosa 6 fosfato deshidrogenasa. Tamizaje, diagnóstico y tratamiento 1o, 2o y 3er nivel de atención. Evidencias y Recomendaciones Catálogo Maestro de Guías de Práctica Clínica: IMSS-247-16.

  11. Diagnóstico y tratamiento del paciente con Hiperplasia Suprarrenal Congénita por deficiencia de 21-hidroxilasa. Guía de Referencia Rápida. Catálogo Maestro de Guías de Práctica Clínica: IMSS-715-14




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med MD. 2017;8.9